Merck & Co., Inc. (MRK): Competition From Generics, Currency Movements ...

25-10-2013 Seeking AlphaComments (0)

ClarinexGenericsMaxaltMerck & CoPropeciaSingulair

Merck is facing tremendous competition from low priced generics due to patent expiry of its several major drugs including Singulair, Propecia, Clarinex, Maxalt, Cozaar and Hyzaar. Out of these, asthma drug Singulair has had the biggest impact and has ...

Read more on Seeking Alpha

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top